Schroder Investment Management Group Neogenomics Inc Transaction History

Schroder Investment Management Group

$94.4 Billion
Q1 2025

A detailed history of Schroder Investment Management Group transactions in Neogenomics Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 4,310,205 shares of NEO stock, worth $31.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,310,205

Previous 3,800,215 13.42%

Holding current value

$31.4 Million

Previous $62.6 Million 34.69%

% of portfolio

0.04%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$9.09 - $18.61 $4.64 Million - $9.49 Million	509,990 Added 13.42%	4,310,205 $40.9 Million
Q4 2024 Feb 12, 2025	SELL	$13.0 - $18.43 $5.45 Million - $7.73 Million	-419,612 Reduced 9.94%	3,800,215 $62.6 Million
Q3 2024 Nov 13, 2024	BUY	$13.4 - $17.73 $284,013 - $375,787	21,195 Added 0.5%	4,219,827 $62.2 Million
Q2 2024 Aug 12, 2024	BUY	$13.01 - $15.77 $14.2 Million - $17.3 Million	1,094,529 Added 35.26%	4,198,632 $58.2 Million
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $8.77 Million - $10.5 Million	623,679 Added 25.14%	3,104,103 $48.8 Million
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $383,744 - $681,664	-32,883 Reduced 1.31%	2,480,424 $40.1 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $6.43 Million - $9.45 Million	529,178 Added 26.67%	2,513,307 $30.9 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $4.91 Million - $6.91 Million	-348,305 Reduced 14.93%	1,984,129 $31.9 Million
Q1 2023 May 11, 2023	BUY	$9.09 - $19.45 $273,127 - $584,414	30,047 Added 1.31%	2,332,434 $40.6 Million
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $3.71 Million - $6.94 Million	574,815 Added 33.27%	2,302,387 $21.3 Million
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $4.47 Million - $7.33 Million	-568,111 Reduced 24.75%	1,727,572 $14.9 Million
Q2 2022 Aug 11, 2022	SELL	$7.06 - $13.97 $731,098 - $1.45 Million	-103,555 Reduced 4.32%	2,295,683 $18.7 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $6.72 Million - $19.5 Million	553,019 Added 29.95%	2,399,238 $29.2 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $25.6 Million - $40.6 Million	838,228 Added 83.16%	1,846,219 $63 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $42 Million - $52.9 Million	1,007,991 New	1,007,991 $48.6 Million

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $916M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Neogenomics Inc Transaction History